Mortality in Antiepileptic Drug Trials

J Gordon Millichap

doi:10.15844/pedneurbriefs-15-3-11

Mortality in Antiepileptic Drug Trials

Pediatric Neurology Briefs

Volume 15 (2001): Issue 3

By: J Gordon Millichap

Open Access

|Mar 2001

Abstract

The incidence and causes of mortality in patients with epilepsy enrolled in antiepileptic drug (AED) trials, and the risk factors for sudden unexplained death in epilespy (SUDEP) were examined in pooled data from New Drug Applications (NDA), at the Center for Drug Evaluation and Research, US FDA, Rockville, MD.

References

Racoosin JA Feeney J Burkhart G Boehm G Mortality in antiepileptic drug development programs Neurology 2001 Feb 56 4 514 519 10.1212/WNL.56.4.514 11222797
Open DOI Search in Google Scholar Back to article
Walczak TS Leppik IE D’Amelio M Rarick J So E Ahman P Incidence and risk factors in sudden unexpected death in epilepsy: a prospective cohort study Neurology 2001 Feb 56 4 519 525 10.1212/WNL.56.4.519 11222798
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-15-3-11 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 24 - 24

Published on: Mar 1, 2001

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Antiepileptic Drug,

Sudden Unexplained Death in Epilespy,

All-Cause Mortality Rate

© 2001 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 15 (2001): Issue 3